TMT1A and cancer: In our pan-cancer bioinformatics analysis, we conducted a comprehensive investigation of the multi-faceted features of METTL7A, including its expression, prognosis, genetic mutation, epigenetic alteration, mutational tumor heterogeneity, TME immune cell infiltration, and signaling pathway across human cancers.